The new randomized study aims to determine if Vomaris's bioelectric wound dressings, powered by V. Dox Technology, can improve healing rate and reduce signs of inflammation following deroofing procedures.

The first patient has been enrolled in a new study using Vomaris Innovations, Inc.’s s bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).

When tunnels develop under the skin in HS, a surgical procedure called deroofing is commonly done. While this removes painful lesions and preserves the surrounding tissue, it leaves large open wounds.

The new randomized study aims to determine if Vomaris's bioelectric wound dressings, powered by V. Dox Technology, can improve healing rate and reduce signs of inflammation following deroofing procedures. It is being conducted at the University of Miami and is led by Hadar Lev-Tov, MD, MAS, assistant professor at the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami, Miller School of Medicine. 

"Patients with HS suffer tremendously and are in desperate need of well-validated treatment solutions. We are excited about the possibility of using a simple electricity-generating product to reduce inflammation, reduce infection risk without antibiotics, and speed healing. If results are positive this could be an important advancement in HS care,"  says Dr. Lev-Tov in a news release.

"This is an underserved patient population that deserves to be addressed. We are hopeful that results from this trial will provide the evidence needed to give HS patients around the world a valuable new treatment option", said Mike Nagel, President and CEO of Vomaris.

V.Dox Technology is a proprietary pattern of embedded microcell batteries that wirelessly generate electricity in the presence of moisture.  Studies have shown that application of an external electric field (such as those generated by V.Dox Technology) can have an anti-inflammatory effect by altering cellular pathways responsible for inflammation. Studies have also shown that V.Dox Technology kills a broad-spectrum of microbes, including multidrug-resistant and biofilm-forming bacteria, and accelerates cell migration (which is required for healing). Both attributes may prove valuable for HS patients because inflammation, bacteria and bacterial biofilm play a well-recognized role in the healing and recurrence of HS lesions.